[1. Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129:837-847. doi: 10.1161/ CIRCULATIONAHA.113.005119.10.1161/CIRCULATIONAHA.113.005119415130224345399]Open DOISearch in Google Scholar
[2. Colilla S, Crow A, Petkun W, Singer DE, Simon T, Liu X. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol. 2013;112:1142-1147. doi: 10.1016/j.amjcard.2013.05.063.10.1016/j.amjcard.2013.05.06323831166]Open DOISearch in Google Scholar
[3. Ball J, Carrington MJ, McMurray JJ, Stewart S. Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. Int J Cardiol. 2013;167:1807-1824. doi: 10.1016/j.ijcard.2012.12.093.10.1016/j.ijcard.2012.12.09323380698]Open DOISearch in Google Scholar
[4. Oldgren J, Healey JS, Ezekowitz M, et al. RE-LY Atrial Fibrillation Registry Investigators. Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RE-LY Atrial Fibrillation Registry. Circulation. 2014;129:1568-1576. doi: 10.1161/CIRCULATIONAHA.113.005451.10.1161/CIRCULATIONAHA.113.00545124463370]Open DOISearch in Google Scholar
[5. Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2017;00:1-66. doi:10.1093/eurheartj/ehx393.10.1093/eurheartj/ehx39328886621]Open DOISearch in Google Scholar
[6. Wong CK, White HD, Wilcox RG, Criger DA, Califf RM, Topol EJ. New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO-III experience. Am Heart J. 2000;140:878-885.10.1067/mhj.2000.11110811099991]Search in Google Scholar
[7. Romanov A, Martinek M, Pürerfellner H, et al. Incidence of atrial fibrillation detected by continuous rhythm monitoring after acute myocardial infarction in patients with preserved left ventricular ejection fraction, results of the ARREST study. Europace. 2017;8:344. doi: 10.1093/europace/euw344.10.1093/europace/euw34428069838]Open DOISearch in Google Scholar
[8. Schmitt J, Duray G, Gersh BJ, Hohnloser SH. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur Heart J. 2009;39:1038-1045. doi: 10.1093/eurheartj/ehn579.10.1093/eurheartj/ehn57919109347]Search in Google Scholar
[9. Rathore SS, Berger AK, Weinfurt KP, Schulman KA, Oetgen WJ, Gersh BJ. Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes. Circulation. 2000;101:969-974.10.1161/01.CIR.101.9.969]Search in Google Scholar
[10. Kea B, Alligood T, Manning V, Raitt M. A Review of the Relationship of Atrial Fibrillation and Acute Coronary Syndrome. Current emergency and hospital medicine reports. 2016;4:107-118. doi: 10.1007/s40138-016-0105-2.10.1007/s40138-016-0105-2523242128090403]Search in Google Scholar
[11. McManus DD, Huang W, Domakonda KV, et al. Trends in Atrial Fibrillation in Patients Hospitalized with an Acute Coronary Syndrome. The American Journal of Medicine. 2012;125:1076-1084. doi: 10.1016/j.amjmed.2012.05.024.10.1016/j.amjmed.2012.05.024352451523098864]Open DOISearch in Google Scholar
[12. Angeli F, Reboldi G, Garofoli M, et al. Atrial fibrillation and mortality in patients with acute myocardial infarction: a systematic overview and meta-analysis. Curr Cardiol Rep. 2012;14:601-610. doi: 10.1007/s11886-012-0289-3.10.1007/s11886-012-0289-322821004]Open DOISearch in Google Scholar
[13. Jabre P, Roger VL, Murad MH, et al. Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and metaanalysis. Circulation. 2011;123:1587-1593. doi: 10.1161/ CIRCULATIONAHA.110.986661.10.1161/CIRCULATIONAHA.110.986661308277321464054]Open DOISearch in Google Scholar
[14. January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/ HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64:e1-76.]Search in Google Scholar
[15. Mozaffarian D, Benjamin EJ, Go AS, et al. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation. 2016;133:e38-e360. doi: 10.1161/cir.0000000000000350.10.1161/cir.0000000000000350]Open DOISearch in Google Scholar
[16. Ghushchyan V, Nair KV, Page RL 2nd. Indirect and direct costs of acute coronary syndromes with comorbid atrial fibrillation, heart failure, or both. Vasc Health Risk Manag. 2015;11:25-34. doi: 10.2147/VHRM.S72331.10.2147/VHRM.S72331428404725565859]Open DOISearch in Google Scholar
[17. Lau DH, Alasady M, Brooks AG, Sanders P. New-onset atrial fibrillation and acute coronary syndrome. Expert Rev Cardiovasc Ther. 2010;8:941-948. doi: 10.1586/erc.10.61.10.1586/erc.10.6120602555]Search in Google Scholar
[18. Rubenstein JC, Cinquegrani MP, Wright J. Atrial Fibrillation in Acute Coronary Syndrome. Journal of Atrial Fibrillation. 2012;5:551. doi: 10.4022/jAF.551.10.4022/jAF.551]Open DOISearch in Google Scholar
[19. Anne W, Willems R, Roskams T, et al. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation. Cardiovasc Res. 2005;67:655-666. doi: 10.1016/j.cardiores.2005.04.016.10.1016/j.cardiores.2005.04.01615913581]Open DOISearch in Google Scholar
[20. Nguyen BL, Fishbein MC, Chen LS, Chen PS, Masroor S. Histopathological substrate for chronic atrial fibrillation in humans. Heart Rhythm. 2009;6:454-460. doi: 10.1016/j. hrthm.2009.01.010.10.1016/j.hrthm.2009.01.010266213419324302]Open DOISearch in Google Scholar
[21. Spach MS, Josephson ME. Initiating reentry: the role of non-uniform anisotropy in small circuits. J Cardiovasc Electrophysiol. 1994;5:182-209.10.1111/j.1540-8167.1994.tb01157.x]Search in Google Scholar
[22. Greiser M. Calcium signalling silencing in atrial fibrillation. J Physiol. 2017;595:4009-4017. doi: 10.1113/JP273045.10.1113/JP273045547136228332202]Open DOISearch in Google Scholar
[23. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur J Cardiothorac Surg. 2016;50:e1- e88. doi: 10.1093/ejcts/ezw313.10.1093/ejcts/ezw313]Open DOISearch in Google Scholar
[24. Jalife J, Kaur K. Atrial Remodeling, Fibrosis and Atrial Fibrillation. Trends in cardiovascular medicine. 2015;25:475-484. doi: 10.1016/j.tcm.2014.12.015.10.1016/j.tcm.2014.12.015]Open DOISearch in Google Scholar
[25. Kotecha D, Piccini JP. Atrial fibrillation in heart failure: what should we do? Eur Heart J. 2015;36:3250-3257. doi: 10.1093/ eurheartj/ehv513.10.1093/eurheartj/ehv513]Open DOISearch in Google Scholar
[26. Alasady M, Lau D, Brooks A, et al. Atrial ischemia rather than neurohormonal or hemodynamic changes associ¬ated with acute myocardial infarction results in substrate for atrial fibrillation. Heart, Lung and Circulation. 2010;19:S2. doi: 10.1016/j.hlc.2010.06.66810.1016/j.hlc.2010.06.668]Open DOISearch in Google Scholar
[27. Alasady M, Abhayaratna WP, Leong DP, et al. Coronary artery disease affecting the atrial branches is an independent determinant of atrial fibrillation after myocardial infarction. Heart Rhythm. 2011;8:955-960. doi: 10.1016/j. hrthm.2011.02.016.10.1016/j.hrthm.2011.02.016]Search in Google Scholar
[28. Ferreira JP, Santos M. Heart failure and atrial fibrillation: from basic science to clinical practice. Int J Mol Sci. 2015;16:3133-3147. doi: 10.3390/ijms16023133. 29. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33:1787-1847. doi: 10.1093/eurheartj/ehs104.10.3390/ijms16023133.29.etal.ESC2012:2012.(HFA)ESC.J.2012;33:1787-1847.doi:10.1093/eurheartj/ehs104]Open DOISearch in Google Scholar
[30. Kober L, Swedberg K, McMurray JJ, et al. Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure of left ventricular dysfunction. Eur J Heart Fail. 2006;8:591-598. doi: 10.1016/j.ejheart.2005.11.007.10.1016/j.ejheart.2005.11.007]Search in Google Scholar
[31. Kochiadakis GE, Skalidis EI, Kalebubas MD, et al. Effect of acute atrial fibrillation on phasic coronary blood flow pattern and flow reserve in humans. Eur Heart J. 2002;23:734-741. doi: 10.1053/euhj.2001.2894.10.1053/euhj.2001.2894]Open DOISearch in Google Scholar
[32. Ariyarajah V, Malinski M, Khadem A, et al. Relation of recurrence of atrial fibrillation after non-ST-elevation acute myocardial infarction to left atrial abnormality. Am J Cardiol. 2008;101:30-34. doi: 10.1016/j.amjcard.2007.07.044.10.1016/j.amjcard.2007.07.044]Open DOISearch in Google Scholar
[33. Cha YM, Redfield MM, Shen WK, Gersh BJ. Atrial fibrillation and ventricular dysfunction: A vicious electromechanical cycle. Circulation. 2004;109:2839-2843. doi: 10.1161/01. CIR.0000132470.78896.A8.10.1161/01.CIR.0000132470.78896.A8]Open DOISearch in Google Scholar
[34. De Jong AM, Maass AH, Oberdorf-Maass SU, et al. Mechanisms of atrial structural changes caused by stretch occurring before and during early atrial fibrillation. Cardiovasc Res. 2011;89:754-765. doi: 10.1093/cvr/cvq357.10.1093/cvr/cvq357]Open DOISearch in Google Scholar
[35. Guo Y, Lip GY, Apostolakis S. Inflammation in atrial fibrillation. J Am Coll Cardiol. 2012;60:2263-2270. doi: 10.1016/j.jacc.2012.04.063.10.1016/j.jacc.2012.04.06323194937]Open DOISearch in Google Scholar
[36. Liuba L, Ahlomroth H, Jonasson L, et al. Source of inflammatory markers in patients with atrial fibrillation. Europace. 2008;10:848-53. doi: 10.1093/europace/eun111.10.1093/europace/eun11118523031]Search in Google Scholar
[37. Li J, Solus J, Chen Q, et al. Role of inflammation and oxidative stress in atrial fibrillation. Heart Rhythm. 2010;7:438-444. doi: 10.1016/j.hrthm.2009.12.009.10.1016/j.hrthm.2009.12.009284377420153266]Open DOISearch in Google Scholar
[38. Pan M, Zhu JH, Jiang WP, et al. Inflammation: a possible pathogenic link to atrial fibrillation. Med Hypotheses. 2006;67:1305-1307. doi: 10.1016/j.mehy.2006.05.034.10.1016/j.mehy.2006.05.03416824699]Open DOISearch in Google Scholar
[39. Aronson D, Boulos M, Suleiman A, et al. Relation of C-reactive protein and new-onset atrial fibrillation in patients with acute myocardial infarction. Am J Cardiol. 2007;100:753-757. doi: 10.1016/j.amjcard.2007.04.014.10.1016/j.amjcard.2007.04.01417719315]Open DOISearch in Google Scholar
[40. Hwang HJ, Ha JW, Joung B, et al. Relation of inflammation and left atrial remodeling in atrial fibrillation occurring in early phase of acute myocardial infarction. Int J Cardiol. doi: 10.1016/j. ijcard.2009.05.065.10.1016/j.ijcard.2009.05.06519570585]Open DOISearch in Google Scholar
[41. Ma CY, Xu ZY, Wang SP, et al. Change of Inflammatory Factors in Patients with Acute Coronary Syndrome. Chinese Medical Journal. 2018;131:1444-1449. doi: 10.4103/0366-6999.233953.10.4103/0366-6999.233953600681129893361]Open DOISearch in Google Scholar
[42. Meuwissen M, van der Wal AC, Siebes M, et al. Role of plaque inflammation in acute and recurrent coronary syndromes. Netherlands Heart Journal. 2004;12:106-109.]Search in Google Scholar
[43. Centurion OA. Serum biomarkers and source of inflammation in acute coronary syndromes and percutaneous coronary interventions. Cardiovasc Revasc Med. 2016;17:119-128. doi: 10.1016/j.carrev.2016.01.005.10.1016/j.carrev.2016.01.00526905055]Open DOISearch in Google Scholar
[44. Fang L, Moore XL, Dart AM, Wang LM. Systemic inflammatory response following acute myocardial infarction. Journal of Geriatric Cardiology: JGC. 2015;12:305-312. doi: 10.11909/j.issn.1671-5411.2015.03.020.]Search in Google Scholar
[45. Frangogiannis NG. The inflammatory response in myocardialinjury, repair and remodeling. Nature Reviews Cardiology. 2014;11:255-265. doi: 10.1038/nrcardio.2014.28.10.1038/nrcardio.2014.28440714424663091]Open DOISearch in Google Scholar
[46. Sukhija R, Fahdi I, Garza L, et al. Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome. Am J Cardiol. 2007;99:879-884. doi: 10.1016/j. amjcard.2006.11.032.10.1016/j.amjcard.2006.11.03217398176]Open DOISearch in Google Scholar
[47. Frangogiannis NG. Regulation of the inflammatory response in cardiac repair. Circulation Research. 2012;110:159-273. doi: 10.1161/CIRCRESAHA.111.243162.10.1161/CIRCRESAHA.111.243162369013522223212]Open DOISearch in Google Scholar
[48. Seropian IM, Toldo S, Van Tassell BW, Abbate A. Antiinflammatory strategies for ventricular remodeling following ST-segment elevation acute myocardial infarction. J Am Coll Cardiol. 2014;63:1593-1603. doi: 10.1016/j.jacc.2014.01.014.10.1016/j.jacc.2014.01.01424530674]Open DOISearch in Google Scholar
[49. Westman PC1, Lipinski MJ1, Luger D, et al. Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial Infarction. J Am Coll Cardiol. 2016;67:2050-2060. doi: 10.1016/j.jacc.2016.01.073.10.1016/j.jacc.2016.01.07327126533]Open DOISearch in Google Scholar
[50. De Servi S, Mariani M, Mariani G, Mazzone A. C-reactive protein increase in unstable coronary disease cause or effect? J Am Coll Cardiol. 2005;46:1496-1502. doi: 10.1016/j.jacc.2005.05.083.10.1016/j.jacc.2005.05.08316226174]Open DOISearch in Google Scholar
[51. Li JJ, Fang CH. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases. Med Hypotheses. 2004;62:499-506. doi: 10.1016/j. mehy.2003.12.014.10.1016/j.mehy.2003.12.01415050096]Open DOISearch in Google Scholar
[52. van der Meer IM, de Maat MP, Kiliaan AJ, van der Kuip DA, Hofman A, Witteman JC. The value of C-reactive protein in cardiovascular risk prediction: the Rotterdam Study. Arch Intern Med. 2003;163:1323-1328. doi: 10.1001/ archinte.163.11.1323.10.1001/archinte.163.11.132312796068]Open DOISearch in Google Scholar
[53. Sheikh AS, Yahya S, Sheikh NS, et al. C-reactive protein as a predictor of adverse outcome in patients with acute coronary syndrome. Heart Views. 2012;13:7-12. doi: 10.4103/1995-705X.96660.10.4103/1995-705X.96660338519722754634]Open DOISearch in Google Scholar
[54. Valgimigli M, Ceconi C, Malagutti P, et al. Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the cytokine-activation and long-term prognosis in myocardial infarction (C-ALPHA) study. Circulation. 2005;111:863-870. doi: 10.1161/01.CIR.0000155614.35441.69.10.1161/01.CIR.0000155614.35441.6915699251]Search in Google Scholar
[55. Andrie RP, Becher UM, Frommold R, et al. Interleukin-6 is the strongest predictor of 30-day mortality in patients with cardiogenic shock due to myocardial infarction. Crit Care. 2012;16:R152.10.1186/cc11467358074122889197]Search in Google Scholar
[56. Dayawansa NH, Gao XM, White DA, et al. Role of MIF in myocardial ischaemia and infarction: insight from recent clinical and experimental findings. Clin Sci. 2014;127:149-161. doi: 10.1042/CS20130828.10.1042/CS2013082824697297]Open DOISearch in Google Scholar
[57. Engelmann MD, Svendsen JH. Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J. 2005;26:2083-2092. doi: 10.1093/eurheartj/ehi350.10.1093/eurheartj/ehi35015975993]Open DOISearch in Google Scholar
[58. Boos CJ, Anderson RA, Lip GY. Is atrial fibrillation an inflammatory disorder? Eur Heart J. 2006;27:136-149. doi: 10.1093/eurheartj/ehi645.10.1093/eurheartj/ehi64516278230]Open DOISearch in Google Scholar
[59. Patel P, Dokainish H, Tsai P, Lakkis N. Update on the association of inflammation and atrial fibrillation. J Cardiovasc Electrophysiol. 2010;21:1064-1070. doi: 10.1111/j.1540-8167.2010.01774.x.10.1111/j.1540-8167.2010.01774.x20455973]Open DOISearch in Google Scholar
[60. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation. 1997;96:1180-1184.10.1161/01.CIR.96.4.11809286947]Search in Google Scholar
[61. Aviles RJ, Martin DO, Apperson-Hansen C, et al. Inflammation as a risk factor for atrial fibrillation. Circulation. 2003;108:3006-3010. doi: 10.1161/01.CIR.0000103131.70301.4F.10.1161/01.CIR.0000103131.70301.4]Open DOISearch in Google Scholar
[62. Chung MK, Martin DO, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias: Inflammatory mechanisms and persistence of atrial fibrillation. Circulation. 2001;104:2886-2891.10.1161/hc4901.10176011739301]Search in Google Scholar
[63. Kallergis EM, Manios EG, Kanoupakis EM, et al. The role of the post-cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation. Heart. 2008;94:200-204. doi: 10.1136/hrt.2006.108688.10.1136/hrt.2006.10868817575330]Open DOISearch in Google Scholar
[64. Marcus GM, Whooley MA, Glidden DV, Pawlikowska L, Zaroff JG, Olgin JE. Interleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul Study. Am Heart J. 2008;155:303-309. doi: 10.1016/j.ahj.2007.09.006.10.1016/j.ahj.2007.09.006224736618215601]Open DOISearch in Google Scholar
[65. Floria M, Barboi O, Rezus C, et al. Atrial Fibrillation and Gastro-Oesophageal Reflux Disease - Controversies and Challenges. Curr Pharm. 2015;21:3829-3834.10.2174/138161282166615031910000325786404]Search in Google Scholar
[66. Issac TT, Dokainish H, Lakkis NM. Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J Am Coll Cardiol. 2007;50:2021-2028. doi: 10.1016/j.jacc.2007.06.054.10.1016/j.jacc.2007.06.05418021867]Open DOISearch in Google Scholar
[67. Pellegrino PL, Brunetti ND, Gennaro LD, Ziccardi L, Grimaldi M, Biase MD. Inflammatory activation in an unselected population of subjects with atrial fibrillation: links with structural heart disease, atrial remodeling and recent onset. Intern Emerg Med. 2011;8:123-128. doi: 10.1007/s11739-011- 0557-z.10.1007/s11739-011-0557-z]Search in Google Scholar
[68. Marcus GM, Smith L, Ordovas K, et al. Intracardiac and extracardiac markers of inflammation during atrial fibrillation. Heart Rhythm. 2010;7:149-154. doi: 10.1016/j. hrthm.2009.10.004.10.1016/j.hrthm.2009.10.004]Open DOISearch in Google Scholar
[69. Conway DS, Buggins P, Hughes E, Lip GY. Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation. Am Heart J. 2004;148:462-466. doi: 10.1016/j.ahj.2004.01.026.10.1016/j.ahj.2004.01.026]Open DOISearch in Google Scholar
[70. Conway DS, Buggins P, Hughes E, Lip GY. Relation of interleukin-6, C-reactive protein, and the prothrombotic state to transesophageal echocardiographic findings in atrial fibrillation. Am J Cardiol. 2004;93:1368-1373. doi: 10.1016/j. amjcard.2004.02.032.10.1016/j.amjcard.2004.02.032]Open DOISearch in Google Scholar
[71. Aronson D, Boulos M, Suleiman A, et al. Relation of C-reactive protein and new-onset atrial fibrillation in patients with acute myocardial infarction. Am J Cardiol. 2007;100:753-757. doi: 10.1016/j.amjcard.2007.04.014.10.1016/j.amjcard.2007.04.014]Open DOISearch in Google Scholar
[72. Hwang HJ, Ha JW, Joung B, et al. Relation of inflammation and left atrial remodeling in atrial fibrillation occurring in early phase of acute myocardial infarction. Int J Cardiol. 2011;146:28-31. doi: 10.1016/j.ijcard.2009.05.065.10.1016/j.ijcard.2009.05.065]Open DOISearch in Google Scholar
[73. Ren Y, Zeng RX, Li JJ, et al. Relation of C-reactive protein and new-onset atrial fibrillation in patients with acute myocardial infarction: A systematic review and meta-analysis. Int J Cardiol. 2015;190:268-70. doi: 10.1016/j.ijcard.2015.04.152.10.1016/j.ijcard.2015.04.152]Open DOISearch in Google Scholar
[74. Clark DM, Plumb VJ, Epstein AE, Kay GN. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol. 1997;30:1039-1045.10.1016/S0735-1097(97)00254-4]Search in Google Scholar
[75. Roy D, Brugada P, Wellens HJ. Atrial tachycardia facilitating initiation of ventricular tachycardia. Pacing Clin Electrophysiol. 1983;6:47-52.10.1111/j.1540-8159.1983.tb06581.x6188124]Search in Google Scholar
[76. Gronefeld GC, Mauss O, Li YG, Klingenheben T, Hohnloser SH. Association between atrial fibrillation and appropriate implantable cardioverter defibrillator therapy: results from a prospective study. J Cardiovasc Electrophysiol. 2000;11:1208-14.10.1046/j.1540-8167.2000.01208.x11083241]Search in Google Scholar
[77. Vukmirović M, Bošković A, Tomašević Vukmirović I, et al. Predictions and Outcomes of Atrial Fibrillation in the Patients with Acute Myocardial Infarction. Open Medicine. 2017;12:115-124. doi: 10.1515/med-2017-0018.10.1515/med-2017-0018544440428730170]Open DOISearch in Google Scholar
[78. Munger TM, Dong YX, Masaki M, et al. Electrophysiological and hemodynamic characteristics associated with obesity in patients with atrial fibrillation. J Am Coll Cardiol. 2012;60:851-860. doi: 10.1016/j.jacc.2012.03.042.10.1016/j.jacc.2012.03.042]Open DOISearch in Google Scholar
[79. Dernellis J, Panaretou M. C-reactive protein and paroxysmal atrial fibrillation, evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation. Acta Cardiol. 2001;56:375-380.10.2143/AC.56.6.2005701]Search in Google Scholar
[80. Parashar S, et al. New-onset atrial fibrillation after acute myocardial infarction and its relation to admission biomarkers (from the TRIUMPH registry). Am J Cardiol. 2013;112:1390-1395.10.1016/j.amjcard.2013.07.006]Search in Google Scholar
[81. Crenshaw BS, Ward SR, Granger CB, Stebbins AL, Topol EJ, Califf RM. Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. J Am Coll Cardiol. 1997;30:406-413.10.1016/S0735-1097(97)00194-0]Search in Google Scholar
[82. Kinjo K, Sato H, Sato H, Ohnishi Y, Hishida E, Nakatani D. Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention. Am J Cardiol. 2003;92:1150-1154.10.1016/j.amjcard.2003.07.02114609587]Search in Google Scholar
[83. Park MJ, Jung JI, Oh YS, Youn HJ. Assessment of the structural remodeling of the left atrium by 64-multislice cardiac CT: comparative studies in controls and patients with atrial fibrillation. Int J Cardiol. 2012;159:181-186. doi: 10.1016/j. ijcard.2011.02.053.10.1016/j.ijcard.2011.02.05321420185]Open DOISearch in Google Scholar
[84. Jabre P, Jouven X, Adnet F, et al. Atrial fibrillation and death after myocardial infarction: a community study. Circulation. 2011;123:2094-2100. doi: 10.1161/ CIRCULATIONAHA.110.990192.10.1161/CIRCULATIONAHA.110.990192314291421536994]Open DOISearch in Google Scholar
[85. Podolecki T, Lenarczyk R, Kowalczyk J, et al. Effect of type of atrial fibrillation on prognosis in acute myocardial infarction treated invasively. Am J Cardiol. 2012;109:1689-1693. doi: 10.1016/j.amjcard.2012.02.009.10.1016/j.amjcard.2012.02.00922440129]Open DOISearch in Google Scholar
[86. Rene AG, Généreux P, Ezekowitz M, et al. Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial). Am J Cardiol. 2014;113:236-242.10.1016/j.amjcard.2013.09.01624176066]Search in Google Scholar
[87. Guenancia C, Stamboul K, Garnier F, et al. Obesity and newonset atrial fibrillation in acute myocardial infarction: a gender specific risk factor. Int J Cardiol. 2014;176:1039-1041. doi: 10.1016/j.ijcard.2014.07.291.10.1016/j.ijcard.2014.07.29125156840]Open DOISearch in Google Scholar
[88. Siu CW, Jim MH, Ho HH, Miu R, Lee SW, Lau CP. Transient atrial fibrillation complicating acute inferior myocardial infarction: implications for future risk of ischemic stroke. Chest. 2007;132:44-49. doi: 10.1378/chest.06-2733.10.1378/chest.06-273317400657]Open DOISearch in Google Scholar
[89. Laurent G, Dentan G, Moreau D, Zeller M, Laurent Y, Vincent- Martin M. Atrial fibrillation during myocardial infarction with and without ST segment elevation. Arch Mal Coeur Vaiss. 2005;98:608-614.]Search in Google Scholar
[90. Kosmidou I, Chen S, Kappetein AP, et al. New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial. J Am Coll Cardiol. 2018;71:739-748. doi: 10.1016/j. jacc.2017.12.012.10.1016/j.jacc.2017.12.01229447735]Open DOISearch in Google Scholar
[91. Echahidi N, Pibarot P, O’Hara G, Mathieu P. Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery. J Am Coll Cardiol. 2008;51:793-801. doi: 10.1016/j. jacc.2007.10.043.10.1016/j.jacc.2007.10.04318294562]Open DOISearch in Google Scholar
[92. Chelazzi C, Villa G, De Gaudio AR. Postoperative Atrial Fibrillation. ISRN Cardiology. 2011;2011:203179. doi:10.5402/2011/203179.10.5402/2011/203179326250822347631]Search in Google Scholar
[93. Alawami M, Chatfield A, Ghashi R, Walker L. Atrial fibrillation after cardiac surgery: Prevention and management: The Australasian experience. Journal of the Saudi Heart Association. 2018;30:40-46. doi: 10.1016/j.jsha.2017.03.008.10.1016/j.jsha.2017.03.008574403129296063]Open DOISearch in Google Scholar
[94. Alqahtani AAR. Atrial Fibrillation Post Cardiac Surgery Trends Toward Management. Heart Views : The Official Journal of the Gulf Heart Association. 2010;11:57-63. doi: 10.4103/1995- 705X.73212.10.4103/1995-705X.73212300091321187998]Open DOISearch in Google Scholar